N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op18)

• Published in: Oncogene Vol. 5; no. 11; p. 1615
• Main Authors: Hailat, N, Strahler, J, Melhem, R, Zhu, X X, Brodeur, G, Seeger, R C, Reynolds, C P, Hanash, S
• Format: Journal Article
• Language: English
• Published: England 01-11-1990
• Subjects: Cell Division; Chromosomes, Human, Pair 1; Electrophoresis, Gel, Two-Dimensional; Gene Amplification; Genes, myc; Humans; Microtubule Proteins; Neoplasm Proteins - metabolism; Neuroblastoma - genetics; Phosphoproteins - metabolism; Phosphorylation; Proto-Oncogene Proteins c-myc - genetics; Stathmin; Tetradecanoylphorbol Acetate - pharmacology; Tumor Cells, Cultured
• ISSN: 0950-9232

We have recently identified and cloned the gene for a cytosolic polypeptide, designated oncoprotein 18 (Op18), which is expressed in acute lymphocytic leukemia and some solid tumors including neuroblastoma. Op18 is phosphorylated upon treatment of lymphoid cells with phorbol myristate acetate. We have proposed that unphosphorylated Op18 plays a role in cellular proliferation, and that its phosphorylated forms, namely Op18a and Op18b, are associated with diminished cell proliferation. In this study, we report that in neuroblastoma tumors, the phosphorylation of Op18 was substantially diminished with increasing N-myc gene copy number. Treatment of the neuroblastoma cell line SMS-KCNR, which contains 75 copies of the N-myc gene, with retinoic acid for ten days resulted in an increase in Op18 phosphorylation. Our findings provide evidence for distinct patterns of Op18 phosphorylation in neuroblastoma tumors with and without N-myc gene amplification.